收藏切换
The mechanism of immune system action in non-alcoholic fatty liver disease and the prospects for stem cell therapy
收藏切换
Xin BAI1, 2, Minyu LIU1, 2, *
World Clinical Drug | 2024, 45(5) : 530 - 536
Less
收藏切换
World Clinical Drug | 2024, 45(5): 530-536
• Review •
The mechanism of immune system action in non-alcoholic fatty liver disease and the prospects for stem cell therapy
Full
Xin BAI1, 2, Minyu LIU1, 2, *
Affiliations
  • 1.State Key Laboratory of New Drug and Pharmaceutical Process, Shanghai Institute of Pharmaceutical Industry, China State Institute of Pharmaceutical Industry, Shanghai 200437, China
  • 2.Shanghai Professional and Technical Service Center for Biological Material Drug-ability Evaluation, Shanghai Institute of Pharmaceutical Industry, China State Institute of Pharmaceutical Industry, Shanghai 200437, China
Published: 2024-05-10 doi: 10.13683/j.wph.2024.05.014
Outline
收藏切换

Nonalcoholic fatty liver disease (NAFLD), as a widespread chronic hepatic disease, is caused by the accumulation of hepatocellular triglyceride, instigating immunological engagement and accompanied by histopathological alterations. NAFLD's a progressive ailment, and the inflammatory response is the driving force in the progression of NAFLD, with various triggers involving metabolic damage often leading to the activation of different immunocytes. The specific drug for NAFLD remains deficient. Stem cell-derived exosomes, representing an innovative therapeutic modality with minimized immunogenicity, are used to suppress the immune reactions in tissues. This article aimed to explore the pathogenesis of NAFLD and the importance of liver in human immunity, discuss the role of different immunocytes in the pathogenesis and progression of NAFLD, deeply understand the pathogenesis of immunocytes involved in NAFLD, summarize the current immunotherapy, and to provide theoretical support for the design of new immunotherapy.

immune response  /  non-alcoholic fatty liver disease  /  stem cell exosomes  /  immunotherapy
白鑫, 刘珉宇. 非酒精性脂肪肝病中的免疫作用及干细胞疗法的前景. 世界临床药物, 2024 , 45 (5) : 530 -536 . DOI: 10.13683/j.wph.2024.05.014
Xin BAI, Minyu LIU. The mechanism of immune system action in non-alcoholic fatty liver disease and the prospects for stem cell therapy[J]. World Clinical Drug, 2024 , 45 (5) : 530 -536 . DOI: 10.13683/j.wph.2024.05.014
Year 2024 volume 45 Issue 5
16
3
Cite this Article
BibTeX
Article Info
doi: 10.13683/j.wph.2024.05.014
  • Receive Date:2023-11-28
  • Online Date:2026-11-17
  • Published:2024-05-10
Article Data
Affiliations
History
  • Received:2023-11-28
Affiliations
    1.State Key Laboratory of New Drug and Pharmaceutical Process, Shanghai Institute of Pharmaceutical Industry, China State Institute of Pharmaceutical Industry, Shanghai 200437, China
    2.Shanghai Professional and Technical Service Center for Biological Material Drug-ability Evaluation, Shanghai Institute of Pharmaceutical Industry, China State Institute of Pharmaceutical Industry, Shanghai 200437, China
References
Share
https://castjournals.cast.org.cn/joweb/sjlcyw/EN/10.13683/j.wph.2024.05.014
Share to
QR

Scan QR to access full text

Cite this article
BibTeX
Citations
表12种不同金属材料的力学参数
科
Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)
属
Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏
  • BibTeX
  • EndNote
  • RefWorks
  • TxT